OBJECTIVE: This study involves a pilot investigation of associations between marijuana and synthetic cannabis use with PTSD symptoms among a young adult sample of U.S. veterans. METHOD: In a cross-sectional survey of a community sample of 790 young adult U.S. veterans, we assessed demographics, combat severity, marijuana and synthetic cannabis use, expectancies of marijuana use, and PTSD symptoms. RESULTS: Overall, 61.8% and 20.4% of our sample reported lifetime and past-month marijuana use, whereas 17.0% and 3.4% reported lifetime and past-month synthetic cannabis use. Veterans screening positive for PTSD were more likely to use marijuana and synthetic cannabis in their lifetime and in the past month. Positive PTSD screens, as well as greater expectancies that marijuana leads to relaxation and tension reduction, were associated with past-month marijuana use in logistic regression analyses. Expectancies moderated the relationship between PTSD and marijuana use, such that those with positive PTSD screens reporting higher levels of relaxation and tension-reduction expectancies were most likely to report past-month marijuana use. CONCLUSIONS: Our findings suggest an association of PTSD symptoms with marijuana and synthetic cannabis use among young adult U.S. veterans. Future research should further investigate the link between PTSD and marijuana use, as well as the rates and consequences of synthetic cannabis use among veterans.
OBJECTIVE: This study involves a pilot investigation of associations between marijuana and synthetic cannabis use with PTSD symptoms among a young adult sample of U.S. veterans. METHOD: In a cross-sectional survey of a community sample of 790 young adult U.S. veterans, we assessed demographics, combat severity, marijuana and synthetic cannabis use, expectancies of marijuana use, and PTSD symptoms. RESULTS: Overall, 61.8% and 20.4% of our sample reported lifetime and past-month marijuana use, whereas 17.0% and 3.4% reported lifetime and past-month synthetic cannabis use. Veterans screening positive for PTSD were more likely to use marijuana and synthetic cannabis in their lifetime and in the past month. Positive PTSD screens, as well as greater expectancies that marijuana leads to relaxation and tension reduction, were associated with past-month marijuana use in logistic regression analyses. Expectancies moderated the relationship between PTSD and marijuana use, such that those with positive PTSD screens reporting higher levels of relaxation and tension-reduction expectancies were most likely to report past-month marijuana use. CONCLUSIONS: Our findings suggest an association of PTSD symptoms with marijuana and synthetic cannabis use among young adult U.S. veterans. Future research should further investigate the link between PTSD and marijuana use, as well as the rates and consequences of synthetic cannabis use among veterans.
Authors: Matthew Jakupcak; Matthew T Tull; Michael J McDermott; Debra Kaysen; Stephen Hunt; Tracy Simpson Journal: Addict Behav Date: 2010-04-14 Impact factor: 3.913
Authors: David Vlahov; Sandro Galea; Heidi Resnick; Jennifer Ahern; Joseph A Boscarino; Michael Bucuvalas; Joel Gold; Dean Kilpatrick Journal: Am J Epidemiol Date: 2002-06-01 Impact factor: 4.897
Authors: Shannon M Kehle; Amanda G Ferrier-Auerbach; Laura A Meis; Paul A Arbisi; Christopher R Erbes; Melissa A Polusny Journal: Psychol Addict Behav Date: 2011-08-08
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Kristin L Tomlinson; Susan R Tate; Kristen G Anderson; Denis M McCarthy; Sandra A Brown Journal: Addict Behav Date: 2005-06-21 Impact factor: 3.913
Authors: Julia D Buckner; Emily R Jeffries; Ross D Crosby; Michael J Zvolensky; Courtenay E Cavanaugh; Stephen A Wonderlich Journal: Am J Drug Alcohol Abuse Date: 2018-02-14 Impact factor: 3.829
Authors: Peter W Kalivas; Constanza Garcia-Keller; Ritchy Hodebourg; Michael E Meyerink; Ayteria D Crow; Carmela M Reichel Journal: Neuropsychopharmacology Date: 2022-02-10 Impact factor: 8.294
Authors: Anthony Murkar; Pam Kent; Christian Cayer; Jon James; Tony Durst; Zul Merali Journal: Front Behav Neurosci Date: 2019-08-01 Impact factor: 3.558